MyFinsight
Home
Blog
About
Cash and cash
equivalents
$270,026K
(70.24%↑ Y/Y)
Short-term investments
$206,693K
(163.41%↑ Y/Y)
Inventory
$17,103K
(-29.24%↓ Y/Y)
Accounts receivable, net
$15,747K
(7.77%↑ Y/Y)
Prepaid expenses and
other current assets
$7,298K
(3.06%↑ Y/Y)
Property and equipment,
gross
$65,475K
(-2.55%↓ Y/Y)
Construction-in-progress
$560K
(18.39%↑ Y/Y)
Total current assets
$516,867K
(2.14%↑ Y/Y)
Long-term investments
$67,280K
Operating lease
right-of-use asset, net
$24,246K
(-1.31%↓ Y/Y)
Property and equipment,
net
$15,300K
(-32.53%↓ Y/Y)
Other non-current
assets
$3,261K
(-11.43%↓ Y/Y)
Deferred tax asset,
non-current
$264K
Less accumulated
depreciation and...
$50,735K
(12.79%↑ Y/Y)
Total assets
$627,218K
(12.61%↑ Y/Y)
Total liabilities and
stockholders' equity
$627,218K
(12.61%↑ Y/Y)
Total stockholders'
equity
$539,971K
(27.19%↑ Y/Y)
Total liabilities
$87,247K
(-34.12%↓ Y/Y)
Accumulated deficit
-$1,160,237K
(6.82%↑ Y/Y)
Treasury stock at cost
18,580 shares at june...
$46,467K
(0.00%↑ Y/Y)
Additional paid-in capital
$1,745,082K
(1.60%↑ Y/Y)
Total current
liabilities
$56,802K
(-42.05%↓ Y/Y)
Operating lease
liabilities, non-current
$22,167K
(-4.55%↓ Y/Y)
Deferred revenue,
non-current
$3,146K
(12.92%↑ Y/Y)
Deferred grant income,
non-current
$2,896K
(-49.78%↓ Y/Y)
Other non-current
liabilities
$1,114K
(-10.88%↓ Y/Y)
Deferred tax liability
$823K
(-23.87%↓ Y/Y)
Convertible notes,
non-current
$299K
(0.00%↑ Y/Y)
Accumulated other
comprehensive income (loss)
$1,183K
(161.36%↑ Y/Y)
Common stock 0.001 par
value, 600,000 shares...
$410K
(2.50%↑ Y/Y)
Accrued liabilities
$29,608K
(22.31%↑ Y/Y)
Accounts payable
$9,554K
(30.36%↑ Y/Y)
Deferred revenue,
current
$9,144K
(-77.24%↓ Y/Y)
Operating lease
liabilities, current
$5,621K
(10.35%↑ Y/Y)
Deferred grant income,
current
$2,875K
(-11.35%↓ Y/Y)
Back
Back
Balance Sheet
STANDARD BIOTOOLS INC. (LAB)
STANDARD BIOTOOLS INC. (LAB)
source: myfinsight.com